Evidence for the secretion of soluble peptidoglycans by clinical isolates of Staphylococcus aureus.
AUTOR(ES)
Zeiger, A R
RESUMO
Four isolates of Staphylococcus aureus from patients with endocarditis and bacteremia were capable of secreting high-molecular-weight soluble peptidoglycans when grown in a minimal cell wall medium containing penicillin G. Vancomycin was not able to substitute for penicillin G in triggering this secretion. Secretion reflected de novo synthesis of soluble peptidoglycan and was strongly dependent on time of incubation (30 to 60 min), and number of bacteria (2 X 10(8) to 5 X 10(8) colony-forming units per ml), but not on penicillin G concentration (10 to 250 micrograms/ml). The incorporation of alanine into the peptidoglycans secreted in vitro by these isolates incubated in the presence of penicillin G under optimal conditions was variable. The least incorporation of alanine into peptidoglycan occurred with an isolate from a patient treated with nafcillin who had no detectable antipeptidoglycan titer.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=347655Documentos Relacionados
- Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
- Collagen binding in clinical isolates of Staphylococcus aureus.
- Lack of evidence for mutation to erythromycin resistance in clinical strains of Staphylococcus aureus.
- Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus.
- Antiserum agar method for identification of Smith type exopolysaccharides in clinical isolates of Staphylococcus aureus.
